Bio-Techne TECH D&A
D&A at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's D&A?
- Bio-Techne (TECH) reported D&A of $24.17M in Q1 2026.
- How has Bio-Techne's D&A changed year-over-year?
- Bio-Techne's D&A decreased by 12.3% year-over-year, from $27.57M to $24.17M.
- What is the long-term trend for Bio-Techne's D&A?
- Over 4 years (2021 to 2025), Bio-Techne's D&A has grown at a 5.8% compound annual growth rate (CAGR), from $87.75M to $109.9M.
- What does D&A mean?
- The non-cash expense representing the wear and tear or expiration of assets.
- How do you interpret D&A?
- Higher levels indicate significant capital investment in infrastructure or acquisitions, while lower levels may suggest aging assets or a shift to asset-light models.
- How does D&A compare across companies?
- Common in capital-intensive manufacturing; peers with large instrument fleets will have higher values.